Reset filter
Nyckelord
Astma ×
Visa mer Nyckelord
Innehållsförteckning
  1. 1. Klinisk studie
  2. 2. Rutindokumentation
  3. 3. Register- och kohortstudier
  4. 4. Kvalitetssäkring
  5. 5. Datastandard
  6. 6. Frågeformulär för patienter
  7. 7. Medicinsk specialitet
Valda datamodeller

Du måste vara inloggad för att välja flera datamodeller, ladda ner dem eller analysera dem.

495 Sökresultat.
Relevans Bedömning Nya först Gamla först

GSK Influence of PPAR gamma agonist vs. Placebo on allergen-induced late asthmatic response NCT00318630 - Screening Part 3 - Alcohol, Drugs, Tobacco and Laboratory Results

- 2021-09-27 - 1 Formulär, 4 Item-grupper, 77 Dataelement, 1 Språk
Item-grupper: Alcohol, drugs and tobacco, Laboratory result data - Haematology, Laboratory result data - Clinical chemistry, Urinalysis
Study ID: 104385 Clinical Study ID: RES104385 Study Title: A randomised double-blind two-period crossover study to investigate the effect of treatment with repeat doses of a PPAR gamma agonist on the allergen-induced late asthmatic response in subjects with mild asthma compared with repeat doses of placebo Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00318630 https://clinicaltrials.gov/ct2/show/NCT00318630 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: rosiglitazone Trade Name: Avandia XR,Avandia; Rosiglitazone XR,Avandia XR,Avandia Study Indication: Asthma This ODM-file contains Screening Part 3 - Alcohol, Drugs, Tobacco and Laboratory Results.

Effect of inhaled fluticasone furoate/Vilanterol combination on electrocardiographic parameters in healthy subjects, NCT01209026 - Logs and repeat

- 2021-09-27 - 1 Formulär, 3 Item-grupper, 15 Dataelement, 1 Språk
Item-grupper: Administrative data, Adverse event/Concomitant medication/unscheduled assessment check questions, Liver event
Study ID: 102936 Clinical Study ID: HZA102936 Study Title:A randomised, placebo-controlled, four-way crossover repeat dose study to evaluate the effect of the inhaled fluticasone furoate (FF)/GW642444M combination on electrocardiographic parameters, with moxifloxacin as a positive control, in healthy subjects Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01209026 https://clinicaltrials.gov/ct2/show/NCT01209026?term=NCT01209026 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: fluticasone furoate Trade Name: Allermist,Veramyst,Avamys; Veramyst,Avamys,Allermist Study Indication: Asthma The study consists of a screening, 8 treatment periods and a follow up. Treatment periods 1-4 are each 7 days long. Treatment period 1 Days 1-6 (TP1D-D6) Treatment period 1 Day 7 (TP1D7) Treatment period 2 Days 1-6 (TP2D1-D6) Treatment period 2 Day 7 (TP2D7) Treatment period 3 Days 1-6 (TP3D1-D6) Treatment period 3 Day 7 (TP3D7) Treatment period 4 Days 1-6 (TP4D1-D6) Treatment period 4 Day 7 (TP4D7) This document contains logs and repeat. It has to be filled in for the end of study.

Eligibility Childhood Asthma NCT02405962

- 2021-09-20 - 1 Formulär, 1 Item-grupp, 14 Dataelement, 1 Språk
Item-grupp: Criteria
Training Parents by Acceptance and Commitment Therapy for Managing Childhood Asthma Care; ODM derived from: https://clinicaltrials.gov/show/NCT02405962

Eligibility Bronchial Asthma NCT01414868

- 2021-09-20 - 1 Formulär, 2 Item-grupper, 10 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
Leukotriene D4 Bronchial Provocation Test (LTD4-BPT) as an Indicator for the Use of Leukotriene Receptor Antagonist (LTRA); ODM derived from: https://clinicaltrials.gov/show/NCT01414868

Eligibility Asthma NCT00288379

- 2021-09-20 - 1 Formulär, 2 Item-grupper, 10 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
SMILDA - Symbicort®Turbuhaler® Allergan Challenge Study in Allergic Patients With Mild Asthma; ODM derived from: https://clinicaltrials.gov/show/NCT00288379

Eligibility Allergic NCT00836368

- 2021-09-20 - 1 Formulär, 2 Item-grupper, 17 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
In Vitro Basophil Responsiveness to Allergen Challenge After Gamma-tocopherol Supplementation in Allergic Asthmatics; ODM derived from: https://clinicaltrials.gov/show/NCT00836368

Eligibility Asthma NCT02022761

- 2021-09-20 - 1 Formulär, 2 Item-grupper, 44 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
Safety, Tolerability and Pharmacokinetics of Inhaled Laninamivir Octanoate TwinCaps® DPI in Adults With Chronic Asthma; ODM derived from: https://clinicaltrials.gov/show/NCT02022761

Eligibility Asthma NCT01928368

- 2021-09-20 - 1 Formulär, 2 Item-grupper, 11 Dataelement, 1 Språk
Item-grupper: Criteria, Exclusion Criteria
A First-in-Human, Double Blind, Single Dose Study in Healthy Subjects and Subjects With Mild Atopic Asthma.; ODM derived from: https://clinicaltrials.gov/show/NCT01928368

Eligibility Asthma NCT01902290

- 2021-09-20 - 1 Formulär, 2 Item-grupper, 14 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility; ODM derived from: https://clinicaltrials.gov/show/NCT01902290

Eligibility Asthma NCT01993329

- 2021-09-20 - 1 Formulär, 2 Item-grupper, 12 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
A Study to Evaluate the Effect of AF-219 on Methacholine Hyper-reactivity in Subjects With Asthma; ODM derived from: https://clinicaltrials.gov/show/NCT01993329

Eligibility Asthma NCT01435902

- 2021-09-20 - 1 Formulär, 2 Item-grupper, 19 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
A Study of a New Asthma Medicine in Asthmatics Whose Asthma Worsens With Exercise; ODM derived from: https://clinicaltrials.gov/show/NCT01435902

Eligibility Atopy NCT00295737

- 2021-09-20 - 1 Formulär, 2 Item-grupper, 18 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
Effect of an Immunotoxin on Activated Human Macrophages in Those With Allergic Rhinitis or Mild Intermittent Asthma; ODM derived from: https://clinicaltrials.gov/show/NCT00295737

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial